Literature DB >> 6334669

Induction of interleukin-2 and colony-stimulating factors in lymphoid cell cultures activated by mitogenic mycoplasmas.

H Gershon, Y Naot.   

Abstract

Mycoplasmal infections often result in chronic inflammatory diseases that involve both local cell proliferation and chemotactic phenomena. To clarify the mechanisms responsible for these inflammatory reactions, we have examined whether nonspecific activation of host lymphocytes by mitogenic mycoplasmas triggers the production of lymphokines, which influence differentiation and proliferation of lymphocytes, macrophages and granulocytes. Mycoplasma pulmonis and M. neurolyticum were tested for their ability to induce production of interleukin-2 (IL-2) and colony-stimulating factors (CSF) by activated lymphoid cells. Mitogenic doses of membranes purified from M. pulmonis, as well as concanavalin A (ConA), induce rat lymphocytes to produce IL-2. Stimulation with the T cell mitogen ConA induces twice the level of IL-2 than does stimulation with M. pulmonis, which activates both rat B- and T-lymphocytes. Unlike these T cell mitogens, M. neurolyticum, which stimulates rat and mouse B-lymphocytes, lacks the ability to induce production of IL-2. Nevertheless, M. neurolyticum stimulates mouse spleen cells to produce in vitro factors capable of stimulating differentiation of bone marrow cells into colonies of macrophages and granulocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334669

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  4 in total

1.  Activation of a murine T-cell hybridoma by cationized bacteria.

Authors:  D N Shapiro; J Varani; I Ginsburg
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Differential induction of bone marrow macrophage proliferation by mycoplasmas involves granulocyte-macrophage colony-stimulating factor.

Authors:  P M Stuart; G H Cassell; J G Woodward
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Monoclonal antibodies that inhibit mitogenic activity of Mycoplasma pulmonis.

Authors:  Z Lapidot; R Siman-Tov; Y Naot
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 4.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.